SCHEMBL6032865

SCHEMBL6032865

CCNC(C(=O)O)c1cccs1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.42
TP53 P04637 2/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.42
THRB P10828 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TSHR P16473 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX5 P09917 1/20 0.41
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
KEAP1 Q14145 1/20 0.40
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.38
USP2 O75604 1/20 0.38
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6021351 0.87 TSHR (0.41) CYP2C19TP53LMNAPOLBTHRB
SCHEMBL9779355 0.81 CYP2C19 (0.43) CYP2C19TP53LMNAPOLBTHRB
SCHEMBL11534783 0.81 ALOX5 (0.44) CYP2C19TP53LMNAPOLBTHRB
SCHEMBL9326172 0.81 ALOX5 (0.42) CYP2C19TP53LMNAPOLBTHRB
Hydrochloric Acid SCHEMBL8845008 0.80 CYP2C19 (0.39) CYP2C19TP53LMNAPOLBTHRB
SCHEMBL10067953 0.78 MEN1 (0.39) CYP2C19TP53LMNAPOLBTHRB
SCHEMBL11281241 0.77 CES2 (0.47) CYP2C19TP53LMNAPOLBTHRB
SCHEMBL11281237 0.77 CES2 (0.47) CYP2C19TP53LMNAPOLBTHRB
SCHEMBL4693687 0.77 CTSK (0.38) CYP2C19TP53LMNAPOLBTHRB
Methane SCHEMBL11684216 0.77 CYP2C19 (0.46) CYP2C19TP53LMNAPOLBTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060018911-A1 Design of therapeutics and therapeutics POINTILLISTE, INC. 2006-01-26 US disclosed
WO-2005067980-A2 DESIGN OF THERAPEUTICS AND THERAPEUTICS POINTILLISTE, INC. (US) 2005-07-28 WO disclosed